The Ultimate Biotech Stock to Buy With $50 Right Now

Finding great biotech stocks to invest in at a price point of $50 per share (or less) isn't easy. There are plenty of companies in the industry trading for far less money than that, but they tend to be extremely risky clinical-stage biotechs that may no longer exist in five years. On the other hand, the leaders in the sector are often attractive options, but their shares are much more expensive.Fortunately, there are at least a few biotechs that sit somewhere in the middle. One of them is Exelixis (NASDAQ: EXEL), a drugmaker whose shares are currently trading hands for just under $39 apiece. This company looks like a buy right now. Here's why.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool